ecteinascidin 743 has been researched along with Rhabdomyosarcoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aquilano, M; Becherini, C; Campanacci, DA; Francolini, G; Greto, D; Livi, L; Loi, M; Mangoni, M; Melica, ME; Salvatore, G; Salvestrini, V; Santini, C; Sottili, M; Talamonti, C; Valzano, M | 1 |
| Kawai, A; Kondo, T; Nakatani, F; Noguchi, R; Ohtori, S; Ono, T; Sei, A; Sin, Y; Sugaya, J; Takeshita, F; Tsuchiya, R; Yoshida, A; Yoshimatsu, Y | 1 |
| Adamson, PC; Baker, KS; Baruchel, S; Blaney, SM; Krailo, M; Lee-Scott, M; Pappo, A; Villaluna, D; Wu, B | 1 |
| Colombo, T; D'Incalci, M; Faircloth, G; Jose, J; Meco, D; Riccardi, A; Riccardi, R; Ubezio, P; Zaffaroni, M; Zucchetti, M | 1 |
| Cavallini, E; Colombo, T; D'Incalci, M; Erba, E; Faircloth, GT; Ferrarese, L; Giavazzi, R; Jimeno, J; Meco, D; Nicoletti, I; Riccardi, R; Sessa, C; Ubezio, P | 1 |
| D'Incalci, M; Faircloth, GT; Jimeno, J; Marabese, M; Mazzarella, G; Meco, D; Riccardi, A; Riccardi, R; Ubezio, P | 1 |
1 trial(s) available for ecteinascidin 743 and Rhabdomyosarcoma
| Article | Year |
|---|---|
A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group.
Topics: Adolescent; Adult; Algorithms; Antineoplastic Agents, Alkylating; Bone Neoplasms; Child; Child, Preschool; Dioxoles; Dose-Response Relationship, Drug; Female; Humans; Male; Medical Oncology; Pediatrics; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Societies, Medical; Soft Tissue Neoplasms; Tetrahydroisoquinolines; Trabectedin; Young Adult | 2012 |
5 other study(ies) available for ecteinascidin 743 and Rhabdomyosarcoma
| Article | Year |
|---|---|
Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells.
Topics: Antineoplastic Agents, Alkylating; Fibrosarcoma; Humans; Leiomyosarcoma; Liposarcoma; Radiation-Sensitizing Agents; Rhabdomyosarcoma; Sarcoma; Soft Tissue Neoplasms; Trabectedin; Tumor Microenvironment | 2022 |
Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma.
Topics: Adult; Antineoplastic Agents; Bortezomib; Cell Line, Tumor; Dactinomycin; Depsipeptides; Gene Fusion; Head and Neck Neoplasms; Humans; Male; Muscle Proteins; Mutation; MyoD Protein; Nuclear Receptor Coactivator 2; Rhabdomyosarcoma; Sarcoma; Trabectedin; Transcription Factors | 2021 |
Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Dioxoles; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Inhibitory Concentration 50; Isoquinolines; Mice; Mice, Inbred C3H; Mice, Nude; Neoplasm Transplantation; Rhabdomyosarcoma; Tetrahydroisoquinolines; Tissue Distribution; Trabectedin; Tumor Cells, Cultured | 2003 |
The combination of yondelis and cisplatin is synergistic against human tumor xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dioxoles; Drug Synergism; Female; Humans; Isoquinolines; Mice; Neoplasm Transplantation; Ovarian Neoplasms; Rhabdomyosarcoma; Tetrahydroisoquinolines; Trabectedin; Transplantation, Heterologous; Tumor Cells, Cultured | 2003 |
Combination of trabectedin and irinotecan is highly effective in a human rhabdomyosarcoma xenograft.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Dioxoles; DNA Topoisomerases, Type I; Humans; In Vitro Techniques; Irinotecan; Isoquinolines; Male; Mice; Mice, Nude; Rhabdomyosarcoma; Tetrahydroisoquinolines; Trabectedin; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2005 |